Moderate and Severe Preoperative Chronic Kidney Disease Worsen Clinical Outcomes After Transcatheter Aortic Valve Implantation
- 1 February 2015
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation: Cardiovascular Interventions
- Vol. 8 (2), e002220
- https://doi.org/10.1161/circinterventions.114.002220
Abstract
Background— There is a conflicting evidence on safety and efficacy of transcatheter aortic valve implantation in patients with preoperative chronic kidney disease (CKD). Therefore, we conducted a meta-analysis on the impact of CKD on outcomes after transcatheter aortic valve implantation. Methods and Results— Nine studies including 4992 patients were analyzed. Overall preoperative CKD (stages 3–5) significantly increased early (odds ratio [OR], 1.44; 95% confidence interval [CI], 1.08–1.94 and OR, 1.66; 95% CI, 1.04–2.67) and 1-year (OR, 1.66; 95% CI, 1.23–2.25 and OR, 1.32; 95% CI, 1.06–1.63) all-cause and cardiovascular mortality, respectively. Moderate CKD (stage 3) alone also increased early and 1-year all-cause mortality (OR, 1.43; 95% CI, 1.10–1.85 and OR, 1.41; 95% CI, 1.13–1.74). CKD stages 4 to 5 and 3 compared with stages 1 to 2 increased early stroke (OR, 2.67; 95% CI, 1.53–4.65 and OR, 1.66; 95% CI, 1.09–2.52), acute kidney injury (OR, 2.09; 95% CI, 1.17–3.72 and OR, 1.32; 95% CI, 1.09–1.60) and need for dialysis (OR, 5.92; 95% CI, 2.46–14.27 and OR, 1.55; 95% CI, 0.65–3.70), in the absence of significant differences in contrast medium administration (mean difference, −26.07; 95% CI, −53.00 to 0.85 and mean difference, −0.42; 95% CI, −16.10 to 15.26). Bleeding (life-threatening or major) was nonsignificantly increased in CKD 3 to 5 compared with CKD 1 to 2, but significantly increased in most severe patients (CKD 4–5 versus CKD 1–2: OR, 1.66; 95% CI, 1.13–2.44; CKD 4–5 versus CKD 3: OR, 1.68; 95% CI, 1.27–2.24). Conclusions— Both moderate and severe preoperative CKD significantly worsen transcatheter aortic valve implantation prognosis. Future studies on risk evaluation, prevention, and postoperative management are needed.Keywords
This publication has 25 references indexed in Scilit:
- Advanced chronic kidney disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes and prognostic markers from a large cohort of patientsEuropean Heart Journal, 2014
- Predictors of One-Year Mortality After Transcatheter Aortic Valve Implantation for Severe Symptomatic Aortic StenosisThe American Journal of Cardiology, 2013
- Long-Term Outcomes After Transcatheter Aortic Valve Implantation in High-Risk Patients With Severe Aortic Stenosis: The U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) RegistryJournal of the American College of Cardiology, 2011
- Aortic valve surgery: Marked increases in volume and significant decreases in mechanical valve use—an analysis of 41,227 patients over 5 years from the Society for Cardiothoracic Surgery in Great Britain and Ireland National databaseThe Journal of Thoracic and Cardiovascular Surgery, 2011
- One-Year Outcomes of Cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) RegistryCirculation, 2011
- Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk PatientsThe New England Journal of Medicine, 2011
- Incidence and Predictors of Early and Late Mortality After Transcatheter Aortic Valve Implantation in 663 Patients With Severe Aortic StenosisCirculation, 2011
- Impact of Recovery of Renal Function on Long-Term Mortality After Coronary Artery Bypass GraftingThe American Journal of Cardiology, 2010
- Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo SurgeryThe New England Journal of Medicine, 2010
- Transcatheter Aortic Valve Implantation for the Treatment of Severe Symptomatic Aortic Stenosis in Patients at Very High or Prohibitive Surgical Risk: Acute and Late Outcomes of the Multicenter Canadian ExperienceJournal of the American College of Cardiology, 2010